Literature DB >> 4542343

Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.

G R Flannery, P J Chalmers, J M Rolland, R C Nairn.   

Abstract

The development of cellular immunity to a syngeneic squamous cell carcinoma in Wistar rats was studied by in vitro microcytotoxicity assay. Reactivity of lymphocytes from lymph nodes, spleen and blood was tested throughout the period of tumour growth. Maximum lymphocyte cytotoxicity against the tumour was observed at 2 weeks in regional lymph nodes, 4 weeks in intermediate nodes, spleen and blood, and 6 weeks in distant nodes; the intensity of these cytotoxic responses subsequently declined. In the regional nodes, lymphocytes became totally unresponsive despite the maintenance of significant cytotoxicity in intermediate nodes, spleen and blood. Local anergy may account for tumour spread to the regional node in an otherwise immunocompetent host. This anergy may be due to high local concentration of tumour antigen or antigen-antibody complexes, but it was not associated with selective changes in T and B cell proportions.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542343      PMCID: PMC2008887          DOI: 10.1038/bjc.1973.129

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  A transient cytotoxic host response to the Rous sarcoma virus-induced transplantation antigen.

Authors:  C J Bellone; M Pollard
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

2.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

3.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

4.  In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response.

Authors:  D Benezra; A Hochman
Journal:  Isr J Med Sci       Date:  1971-04

5.  Prospects for immunotherapy of cancer: experience in experimental systems.

Authors:  P Alexander
Journal:  Br Med J       Date:  1970-11-21

6.  Tumor-distinctive cellular immunity to human sarcoma and carcinoma.

Authors:  F Vánky; J Stjernswärd
Journal:  Isr J Med Sci       Date:  1971-01

7.  The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.

Authors:  M Loring; M Schlesinger
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

Review 8.  Human tumor immunology.

Authors:  H F Oettgen; L J Old; E A Boyse
Journal:  Med Clin North Am       Date:  1971-05       Impact factor: 5.456

9.  Tumour-specific immunity against spontaneous rat tumours.

Authors:  R W Baldwin
Journal:  Int J Cancer       Date:  1966-05-15       Impact factor: 7.396

10.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

View more
  13 in total

1.  Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity.

Authors:  N Matthews; T de Kretser; R C Nairn
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Lymphotoxin production by regional lymph node lymphocytes in patients with uterine cervical cancer.

Authors:  K Matsunaga; H Mashiba; A Kurano; S Jimi
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

Review 3.  Role of the regional lymph node in cancer metastasis.

Authors:  T Tachibana; K Yoshida
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 4.  Recurrent and metastatic malignant disease: immunological considerations.

Authors:  R L Carter
Journal:  Proc R Soc Med       Date:  1974-09

5.  The migration of lymphoid cells in malignant disease.

Authors:  R Stein-Werblowsky
Journal:  Experientia       Date:  1974-04-15

6.  The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.

Authors:  I J Check; M Cobb; R L Hunter
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

7.  Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.

Authors:  H Matsunaga; Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1988-10

8.  Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.

Authors:  P J Chalmers; N Matthews; R C Nairn
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

9.  Survival of F1 hybrid rats inoculated with a strain specific transplantable carcinoma following the induction of a systemic graft-versus-host reaction.

Authors:  J Rumma; D J Davies
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

10.  Changes in host immunity following excision of a murine melanoma.

Authors:  A E Bray; D Keast
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.